RxDoctor Payments Data

Richard Powell, MD

Internal Medicine · New Port Richey, FLNPI 1023103702

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $11,145 of the $12,125 with a category attached, or 91.9%. Novo Nordisk AS accounts for 74.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $8,999 and has fallen 65.7% since, to $3,086 in 2023. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,125in general payments, 2019–2025

Across 22 payments — averaging $551.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$9K
  • Modernatx, Inc.$2K
  • Biogen$1K
  • Vanda Pharmaceuticals Inc.$29
  • Electromed, Inc.$17
  • Amarin Pharma, Inc.$11
$8,063,867in research payments, 2019–2025

Across 3,380 payments — averaging $2385.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$3.1M
  • Janssen Research & Development, LLC$2.6M
  • Johnson & Johnson$488K
  • Roche Diagnostics Operations, Inc.$292K
  • Seqirus USA Inc$268K
  • Pfizer$250K
  • plus $1M from 18 others

What the payments were for

  • Travel & lodging$11,14592%
  • Food & beverage$9808%

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,125 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$17,660
Medicare patients
47
Services billed
178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in New Port Richey

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →